Krawczyk N, Miller M, Frank D, Harris SJ, O'Rourke A, Song M, Ruelas-Vargas K, Gibbons JB, Jordan A, Saloner B - International Journal of Drug Policy
Using New York’s early rollout as a case study, the authors describe how mobile methadone units remain hamstrung by security rules, high costs, requirements to return daily to a home clinic and stay within state lines, and community opposition. The authors argue that without a broader shift away from “methadone exceptionalism,” mobile units will remain a modest convenience rather than a transformative way to close treatment gaps.
VIEW SOURCE
Eisenkraft Klein D, Kesselheim AS - Clinical Pharmacology & Therapeutics
Cai CL, Bucha S, Kesselheim AS, Rome BN - Journal of General Internal Medicine
Chen NC, Bullement A, Zemplenyi AT, O'Bryant CL, Kaizer AM, Anderson KE, McQueen RB - PharmacoEconomics Open